Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBT Margin Growth (1y)EBT Margin Growth (3y)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin Growth (1y)FCF Margin Growth (3y)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Interest Coverage Ratio Growth (5y)Net Margin Growth (1y)Net Margin Growth (3y)Operating Margin Growth (1y)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)
Income Statement
Others
Ratios

Innate Pharma (IPHA) Interest Coverage Ratio Growth (1y) (2020 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 15.31%
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn -76.51%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -303.06%
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn -26.72%
8 Evaxion A 65.44 Bn 65.42 Bn - 18.06%
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 1,150.63%
10 Innate Pharma 199.64 Mn 199.64 Mn - 24.66%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 24.66%
Jun 30, 2025 -28.84%
Dec 31, 2024 162.33%
Jun 30, 2024 2,994.25%
Dec 31, 2023 -56.91%
Dec 31, 2022 -0.59%
Dec 31, 2021 965.87%
Dec 31, 2020 -78.29%